Will determine the regulatory connectivity(s) in the PISK signaling network in a panel of luminal breast tumor cell lines using an unbiased systems approach and develop and test a robust mathematical model of the signaling to predict combinations for therapy. This project is motivated by the observation that the PISK network is selectively activated by mutation in luminal and HER2 positive tumors and represents the most frequent activating event in luminal breast cancers. PISK signaling regulates breast cancer proliferation, survival, cytokine production, protein translation, cell growth, bioenergetics and metastasis. Aberrations that activate PISK signaling can occur either extrinsically at the receptor level (HER2) or intrinsically within the network (RAS, PIKSCA, PIK3CR1, PDK1, AKT or PTEN). Furthermore, as demonstrated in this CCSB, the activation state ofthe PISK network determines outcomes to drugs targeting the HER2 network. Despite the evidence defining the PISK network as a high quality target, regulatory feedback loops as well as cross talk with other networks (MAPK) make understanding and targeting the PISK network a challenging task. One of the key goals will be develop robust predictive models able to determine rational combinatorial approaches to target aberrations in the PISK network and at the same time prevent deleterious effects of feedback loops and cross talk. Experimentally, this will be accomplished by determining PISK signaling network connectivity in 4 breast cell lines by targeted knockdown of all kinases followed by phospho-proteomic analysis. This connectivity network will be combined with the dynamic data from Project 1 to develop an ODE model that describes the AKT centric network response. The model can them be used to analyze patient data and determine combinations of drugs based on the specific signaling signature in the tumor tissue. We hypothesize that nested feedback loops in the PISK network and cross talk confer complex regulatory mechanisms that will need to be targeted. As a corollary, predictive computational models will have the power to identify rational drug combinations to effectively inhibit PISK network signaling and thus cell proliferation survival and metastasis. Models developed in this project will be informed by network development efforts in Project 1 and will contribute to development of models of response to MEK and HER2/3 inhibitors in Projects 2 and 3, respectively.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-C)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Oregon Health and Science University
United States
Zip Code
Werner, Henrica M J; Mills, Gordon B; Ram, Prahlad T (2014) Cancer Systems Biology: a peek into the future of patient care? Nat Rev Clin Oncol 11:167-76
Akbani, Rehan; Ng, Patrick Kwok Shing; Werner, Henrica M J et al. (2014) A pan-cancer proteomic perspective on The Cancer Genome Atlas. Nat Commun 5:3887
Lee, Jiyoung; Lee, Jinho; Farquhar, Kevin S et al. (2014) Network of mutually repressive metastasis regulators can promote cell heterogeneity and metastatic transitions. Proc Natl Acad Sci U S A 111:E364-73
Hines, William C; Su, Ying; Kuhn, Irene et al. (2014) Sorting out the FACS: a devil in the details. Cell Rep 6:779-81
Mertins, Philipp; Yang, Feng; Liu, Tao et al. (2014) Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics 13:1690-704
Nishikawa, Taichiro; Bellance, Nad├Ęge; Damm, Aaron et al. (2014) A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease. J Hepatol 60:1203-11
Iadevaia, Sergio; Nakhleh, Luay K; Azencott, Robert et al. (2014) Mapping network motif tunability and robustness in the design of synthetic signaling circuits. PLoS One 9:e91743
Hoadley, Katherine A; Yau, Christina; Wolf, Denise M et al. (2014) Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 158:929-44
Cope, Leslie M; Fackler, Mary Jo; Lopez-Bujanda, Zoila et al. (2014) Do breast cancer cell lines provide a relevant model of the patient tumor methylome? PLoS One 9:e105545
Oates, Chris J; Dondelinger, Frank; Bayani, Nora et al. (2014) Causal network inference using biochemical kinetics. Bioinformatics 30:i468-74

Showing the most recent 10 out of 110 publications